ANDREA BRUSH: Open Payments
NPI 1790469955 · PRATTVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,491 in 77 payments from 20 companies in 2025. Trend: 2023 $80 · 2024 $1,274 · 2025 $1,491
Food & beverage: $1,491
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $255 |
| ABBVIE INC. | 14 | $213 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $164 |
| PFIZER INC. | 7 | $137 |
| Lilly USA, LLC | 7 | $121 |
| GlaxoSmithKline, LLC. | 5 | $98 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Almatica Pharma LLC | 3 | $74 |
| Lundbeck LLC | 3 | $55 |
| Novo Nordisk Inc | 2 | $45 |
Products named: BREZTRI, CAPLYTA, REXULTI, VRAYLAR, MOUNJARO, UBRELVY, ELIQUIS, TRELEGY ELLIPTA.
Industry payments across AL — which companies pay providers there.
